Skip to main content

Ligand Pharmaceuticals Inc. (NASDAQ:LGND) Investor Investigation Over Potential Wrongdoing Announced

  • If you purchased shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND), you have certain options and you should contact the Shareholders Foundation, Inc.

  • To have your information reviewed for options and to receive notifications about this case, please use this form. You may also send an email to mail@shareholdersfoundation.com, or call us at (858) 779-1554.

Site Members can sign up for company wide alerts

Investigation Overview

May 21, 2013 (Shareholders Foundation) - An investigation on behalf of current long-term stockholders of shares of Ligand Pharmaceuticals Inc. (NASDAQ:LGND) was announced concerning whether certain Ligand Pharmaceuticals officers and directors possibly breached their fiduciary duties in connection with certain statements. The investigation by a law firm concerns whether certain Ligand...



You must register (for free) or login to view the entire investigation.